Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion

Coverage, in order

1. 7d ago
   GEN Genetic Engineering News indie

   Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion

   Recently, the Orphan Therapeutics Accelerator (OTXL) announced an agreement with UCL Ventures, the commercialization company of University College London (UCL), and Children’s Medical Research Institute (CMRI) to in-license an investigational therapy program for ornithine transcarbamylase…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.